Given that PLD2 is mandatory for mTOR and S6K signaling in MDA-MB-468 breast cancer cells [34], it can be concluded that this pathway was most likely involved in MDA-NEO and MDA-HER2 cell migration since both cell lines were derived from MDA-MB-468 cells [9, 12]. The gene discussed is MTOR; the disease is breast cancer.